Quick Search Headache Quick Search Triplans Quick Search MIDAS Home Understanding Migraine Treating Migraine Triptans Resources
Triptans
Zomig
Nasal Spray
Rapimelt
Classic Tablet
Full Perscribing Information
 
 
 

Zomig Nasal Spray

Very fast onset of action

True, fast, reliable intranasal absorption of Zolmitriptan with active drug detected in plasma within 2 minutes and in the brain within 5 minutes after dosing. Significant headache response within 10 minutes and pain free outcome within 15 minutes, compared with placebo. Patients can be free from all the major symptoms of migraine as early as 30 minutes after treatment.

'Zomig' Nasal Spray is the fastest patient-friendly migraine treatment!

True intranasal absorption of 'Zomig' Nasal

 

True intranasal absorption of 'Zomig' nasal

 

Zolmitriptan is detectable in plasma as early as 2 minutes

 

Zolmitriptan is detectable in the brain 5 minutes after administration

 

headache response

 

Pain- free rates

 

Total symptom relief

 

First-class efficacy

Effective headache relief within 2 hours for more than 70% of all patients. Efficacy that lasts all day. High headache response and pain free outcomes were maintained in individual patients across attacks throughout the duration of a one-year long-term study. Very high efficacy for patients treating early in the course of the attack, with up to 87% of patients experiencing freedom from headache pain at 2 hours after dosing with Zomig Nasal Spray.

high 2-hour headache

 

Long- lasting efficacy

 

High headache response

 

Very high 2-hour pain- free rates

High treatment satisfaction for patients

Patients report high treatment satisfaction with 70% of patients stating that this treatment is good or excellent following long-term use. More than 75% of patients are satisfied with the reliability and speed of relief of 'Zomig' Nasal Spray and as many as 90% find it easy to use.

Around 70% of patients who use Zomig Nasal Spray to treat migraine say they want to continue to use it in future.

Less than 1% of all patients opted to withdraw from clinical trials, confirming patient tolerability, acceptability and compliance with treatment.

patient satisfaction

 

High levels of satifcation

 

most patients who try Zomig
Top 6 reasons for wishing to continue to use

 
Developed in partnership with AstraZeneca by EPG Online
 
Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in